Literature DB >> 16798830

Controlled reperfusion after hypothermic heart preservation inhibits mitochondrial permeability transition-pore opening and enhances functional recovery.

J C Bopassa1, David Vandroux, M Ovize, R Ferrera.   

Abstract

We investigated whether low-pressure reperfusion may attenuate postischemic contractile dysfunction, limits necrosis and apoptosis after a prolonged hypothermic ischemia, and inhibits mitochondrial permeability transition-pore (MPTP) opening. Isolated rats hearts (n = 72) were exposed to 8 h of cold ischemia and assigned to the following groups: 1) reperfusion with low pressure (LP = 70 cmH(2)O) and 2) reperfusion with normal pressure (NP = 100 cmH(2)O). Cardiac function was assessed during reperfusion using the Langendorff model. Mitochondria were isolated, and the Ca(2+) resistance capacity (CRC) of the MPTP was determined. Malondialdehyde (MDA) production, caspase-3 activity, and cytochrome c were also assessed. We found that functional recovery was significantly improved in LP hearts with rate-pressure product averaging 30,380 +/- 1,757 vs. 18,000 +/- 1,599 mmHg/min in NP hearts (P < 0.01). Necrosis, measured by triphenyltetrazolium chloride staining and creatine kinase leakage, was significantly reduced in LP hearts (P < 0.01). The CRC was increased in LP heart mitochondria (P < 0.01). Caspase-3 activity, cytochrome c release, and MDA production were reduced in LP hearts (P < 0.001 and P < 0.01). This study demonstrated that low-pressure reperfusion after hypothermic heart ischemia improves postischemic contractile dysfunction and attenuates necrosis and apoptosis. This protection could be related to an inhibition of mitochondrial permeability transition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798830     DOI: 10.1152/ajpheart.00209.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Protection of the ischemic myocardium during the reperfusion: between hope and reality.

Authors:  Jean Chrisostome Bopassa
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

2.  Mitochondrial free [Ca2+] increases during ATP/ADP antiport and ADP phosphorylation: exploration of mechanisms.

Authors:  Johan Haumann; Ranjan K Dash; David F Stowe; Age D Boelens; Daniel A Beard; Amadou K S Camara
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

3.  Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1.

Authors:  Ken Shinmura; Kayoko Tamaki; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

4.  Oxidants and Ca+2 induce PGC-1alpha degradation through calpain.

Authors:  Kyle A Rasbach; Peter T Green; Rick G Schnellmann
Journal:  Arch Biochem Biophys       Date:  2008-08-08       Impact factor: 4.013

5.  Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.

Authors:  Terhi Karpanen; Maija Bry; Hanna M Ollila; Tuulikki Seppänen-Laakso; Erkki Liimatta; Hanna Leskinen; Riikka Kivelä; Teemu Helkamaa; Mari Merentie; Michael Jeltsch; Karri Paavonen; Leif C Andersson; Eero Mervaala; Ilmo E Hassinen; Seppo Ylä-Herttuala; Matej Oresic; Kari Alitalo
Journal:  Circ Res       Date:  2008-08-28       Impact factor: 17.367

6.  A novel survival model of cardioplegic arrest and cardiopulmonary bypass in rats: a methodology paper.

Authors:  Fellery de Lange; Kenji Yoshitani; Mihai V Podgoreanu; Hilary P Grocott; G Burkhard Mackensen
Journal:  J Cardiothorac Surg       Date:  2008-08-19       Impact factor: 1.637

Review 7.  Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium.

Authors:  Daniel I Bromage; Sean M Davidson; Derek M Yellon
Journal:  Pharmacol Ther       Date:  2014-04-01       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.